Clinical Trial Update: Intravenous Versus Oral Iron Therapy in Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing intravenous versus oral iron therapy in hemodialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hemodialysis Complications
• Iron Deficiency Anemia

Snippet

Sponsor: Chiang Mai University | Conditions: Hemodialysis Complication, Anemia | Phase 3 | Status: UNKNOWN